Skip to main content
EURAXESS

Ph.D. Fellowship (SSBCV) : FUNTIONAL CHARACTERISATION OF CYSTEINE CATHEPSINS IN THE APICOMPLEXAN PARASITE CRYPTOSPORIDIUM PARVUM

Details

Deadline
Research Field
Formal sciences
Funding Type
Funding

About

Keywords
Cryptosporidium parvum, apicomplexan parasite , host-pathogen interactions, virulence factors, cysteine cathepsins
 
Profile and skills required
The candidate must be in the last year of its Master’s (or equivalent) degree, or already hold a Master’s degree (or equivalent), preferably in biology or microbiology.
We are looking for a curious and motivated student with strong critical thinking skills, enjoying teamwork but also capable to work in autonomy.
Past experience of internship in a research laboratory in the field of infectious diseases or parasitology would be appreciated. Technical skills involving cell culture (biosafety level 2 laboratory), molecular biology (RT-qPCR, cloning, transfection) and/or biochemistry (enzyme assay) would also be appreciated.
It is important to stress that the PhD project requires some animal experimentation.
The student must have very good written and oral communication skills in both French and English.

Niveau de français requis: Intermédiaire supérieur: Vous pouvez utiliser la langue de manière efficace et vous exprimer précisément.

Niveau d'anglais requis: Intermédiaire supérieur: Vous pouvez utiliser la langue de manière efficace et vous exprimer précisément.

 
Project description
Cryptosporidium parvum is an apicomplexan parasite responsible for cryptosporidiosis, a
zoonotic disease affecting both human and animal health. This diarrhoeal disease, and its
associated clinical symptoms, can be severe and lead to death in some cases, in particular in neonates and immunocompromised individuals. The authorised drugs that are currently used to treat cryptosporidiosis are not completely effective as they do not provide a total clearance of the parasite, and no vaccine is available. A better understanding of the biology of the parasite, and of the host-Cryptosporidium interactions, is crucial in order to identify new therapeutic targets and develop new control strategies.
Cysteine cathepsins are proteolytic enzymes that hydrolyse a peptide bond on a
substrate protein using the thiol group of a cysteine residue as a nucleophile. Cysteine
cathepsins expressed by different protozoan parasites have been shown to play key roles in their associated pathogenesis (e.g. invasion of host cells or tissues, hydrolysis of proteins from the host or from the parasite itself, modulation of the host immune response), making them attractive chemotherapeutic and vaccine targets.
The genome of C. parvum harbours five genes encoding putative cysteine cathepsins
(also named ‘cryptopains’), but these proteases have only been scarcely studied so far. This PhD project aims at describing the cathepsin activities that are expressed by C. parvum and functionally characterising their role(s) in the parasite’s life cycle by means of biochemical and molecular approaches. The expected results will expand our knowledge of the biology of C. parvum and identify new virulence factors in this parasite species.

 

References
[1] Siqueira-Neto JL, Debnath A, McCall LI, Bernatchez JA, Ndao M, Reed SL, Rosenthal
PJ. Cysteine proteases in protozoan parasites. PLoS Negl Trop Dis. 2018 Aug 23;12(8):e0006512. doi: 10.1371/journal.pntd.0006512

[2] Rawat A, Roy M, Jyoti A, Kaushik S, Verma K, Srivastava VK. Cysteine proteases:
Battling pathogenic parasitic protozoans with omnipresent enzymes. Microbiol Res. 2021
Aug;249:126784. doi: 10.1016/j.micres.2021.126784

[3] Na BK, Kang JM, Cheun HI, Cho SH, Moon SU, Kim TS, Sohn WM. Cryptopain-1, a
cysteine protease of Cryptosporidium parvum, does not require the pro-domain for folding.
Parasitology. 2009 Feb;136(2):149-57. doi: 10.1017/S0031182008005350

[4] Ndao M, Nath-Chowdhury M, Sajid M, Marcus V, Mashiyama ST, Sakanari J, Chow E,
Mackey Z, Land KM, Jacobson MP, Kalyanaraman C, McKerrow JH, Arrowood MJ, Caffrey CR. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection. Antimicrob Agents Chemother. 2013 Dec;57(12):6063-73. doi:
10.1128/AAC.00734-13

[5] Kang JM, Ju HL, Yu JR, Sohn WM, Na BK. Cryptostatin, a chagasin-family cysteine
protease inhibitor of Cryptosporidium parvum. Parasitology. 2012 Jul;139(8):1029-37. doi:
10.1017/S0031182012000297

[6] Swale C, Bougdour A, Gnahoui-David A, Tottey J, Georgeault S, Laurent F, Palencia A,
Hakimi MA. Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls
Cryptosporidium infection. Sci Transl Med. 2019 Nov 6;11(517):eaax7161. doi:
10.1126/scitranslmed.aax7161

 

Attachments

Attachments
Disclaimer:

The responsibility for the funding offers published on this website, including the funding description, lies entirely with the publishing institutions. The application is handled uniquely by the employer, who is also fully responsible for the recruitment and selection processes.